Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

TA151 Diabetes - insulin pump therapy: reveiw decision - May 2011 information

Appendix A: decision paper presented to the Institute's Guidance Executive (PDF 72 KB)

TA151 Diabetes - insulin pump therapy: review proposal - March 2011 information

Appendix A: provisional matrix of stakeholders (PDF 42 KB)

Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 147 KB)

NICE issues updated guidance on the use of insulin pump therapy (PDF 43 KB)

Diabetes - insulin pump therapy: appeal information

Diabetes - insulin pump therapy: Appeal (PDF 13 KB)

Diabetes - insulin pump therapy: appeal announcement information

Appeal received (PDF 37 KB)

Response from Appraisal Committee (PDF 34 KB)

Scrutiny letter (PDF 33 KB)

Diabetes - insulin pump therapy: appeal decision (PDF 26 KB)

Diabetes - insulin pump therapy: (Final appraisal determination)

Diabetes - insulin pump therapy (Final Appraisal Determination) information

Diabetes - insulin pump therapy (Final Appraisal Determination) (PDF 104 KB)

Response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 379 KB)

Consultee and commentator comments on the ACD

Royal College of Physicians (PDF 53 KB)

Royal College of Paediatrics and Child Health (PDF 28 KB)

Royal College of Nursing (PDF 36 KB)

Juvenile Diabetes Research Foundation (PDF 22 KB)

Insulin Dependant Diabetes Trust (PDF 533 KB)

Letter from INPUT (PDF 545 KB)

INPUT (PDF 49 KB)

Diabetes UK (PDF 64 KB)

British Dietetic Association (PDF 22 KB)

Association of British Consultant Diabetologists (PDF 11 KB)

ANIMAS (PDF 13 KB)

Association of British Healthcare Industries (PDF 27 KB)

Expert comments on the ACD

Professor John Pickup (PDF 17 KB)

Mrs Alexandria Moseley (PDF 14 KB)

Mrs Lesley Jordan (PDF 16 KB)

Dr Peter Hammond (PDF 15 KB)

Web comments (PDF 436 KB)

Diabetes - insulin pump therapy (Appraisal consultation document)

Diabetes - insulin pump therapy (Appraisal consultation document) information

Evaluation report

Overview (PDF 122 KB)

Diabetes - insulin pump therapy: assessment report (PDF 1.07 MB)

A cross industry submission from Animas Corporation / Johnson & Johnson Medical Ltd, Medtronic Ltd, Roche Diagnostics Ltd, Smiths Medical International and Starbridge Systems Ltd (PDF 57 KB)

Non-manufacturer submission

Diabetes UK (PDF 102 KB)

Department of Health (PDF 23 KB)

British Dietetic Association (PDF 54 KB)

Association of British Clinical Diabetologists (PDF 53 KB)

Royal College of Physicians - additional response (PDF 43 KB)

Royal College of Physicians (PDF 43 KB)

Royal College of Nursing (PDF 21 KB)

INPUT (PDF 380 KB)

Expert written personal statements

Pickup (PDF 27 KB)

Moseley (PDF 16 KB)

Hammond (PDF 36 KB)

Jordan (PDF 23 KB)

Davis - Readings (PDF 1.22 MB)

Davis - Statement (PDF 40 KB)

Campbell (PDF 15 KB)

Consultee and commentator comments on the assessment report

Royal College of Paediatrics and Child Health (PDF 33 KB)

Royal College of Nursing (PDF 32 KB)

Roche Diagnostics Ltd additional response (PDF 83 KB)

Novo Nordisk Ltd (PDF 647 KB)

Juvenile Diabetes Research Foundation - NICE letter (PDF 18 KB)

Juvenile Diabetes Research Foundation - NICE feedback (PDF 28 KB)

Juvenile Diabetes Research Foundation - Feedback for NICE (PDF 55 KB)

Dose Adjustment of Normal Eating (DAFNE) Steering Group (PDF 23 KB)

Diabetes UK (PDF 55 KB)

Department of Health (PDF 22 KB)

Association of British Clinical Diabetologists (PDF 492 KB)

A cross industry submission from Animas Corporation/ Johnson & Johnson Medical Ltd, Medtronic Ltd, Roche Diagnostics Ltd, Smiths Medical International and Starbridge Systems Ltd (PDF 3.54 MB)

Diabetes - insulin pump therapy: final scope (PDF 46 KB)

Diabetes - insulin pump therapy: comments on draft scope (PDF 124 KB)

Diabetes - insulin pump therapy: Response to consultee and commentator comments on the provisional matrix of consultees and commentators (PDF 39 KB)